Balance Sheet Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-10 pm EDT			5-day change	1st Jan Change
90.49 ^USD	-0.78%		-3.01%	-11.41%

Mar. 10	Guardant Health Inc Announces Shield Blood-Based Screening Test for Colorectal Cancer Is Accessible Through National Test Ordering and Collection Network of Quest Diagnostics	CI
Mar. 05	Guardant Health Insider Sold Shares Worth $3,812,661, According to a Recent SEC Filing	MT

c.IB12StZwrilM5_v8jqzG4jEeGqCCEd-mWtRebldm4lE.EVdEEpUJ1xAfk4GG-8eIqAJYavDhfZLPIpcdVhATqyUQdh8hm0abcyWrjA

Published financial data: GUARDANT HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	374M	450M	564M	739M	982M
Total Revenues	374M	450M	564M	739M	982M
Cost of Goods Sold, Total	123M	156M	227M	290M	349M
Gross Profit	251M	293M	337M	449M	633M
Selling General & Admin Expenses, Total	399M	464M	451M	545M	705M
R&D Expenses	263M	374M	365M	348M	364M
Other Operating Expenses, Total	662M	838M	816M	893M	1.07B
Operating Income	-411M	-544M	-479M	-444M	-436M
Interest Expense, Total	-2.58M	-2.58M	-2.58M	-2.58M	-3.9M
Interest And Investment Income	3.93M	6.07M	35.36M	53.69M	34.1M
Net Interest Expenses	1.35M	3.49M	32.79M	51.11M	30.2M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	178K	-99.47M	2.52M	1.8M	8.09M
EBT, Excl. Unusual Items	-409M	-640M	-444M	-391M	-398M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-13.09M	50.66M	-44.4M	-18.58M
Legal Settlements	-	-	-83.4M	-	-
Other Unusual Items	25M	-	-2.1M	-	-950K
EBT, Incl. Unusual Items	-384M	-653M	-479M	-435M	-418M
Income Tax Expense	300K	1.14M	685K	1.28M	-1.26M
Earnings From Continuing Operations	-385M	-655M	-479M	-436M	-416M
Net Income to Company	-385M	-655M	-479M	-436M	-416M
Minority Interest	-20.9M	-	-	-	-
Net Income - (IS)	-406M	-655M	-479M	-436M	-416M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-406M	-655M	-479M	-436M	-416M
Net Income to Common Excl. Extra Items	-406M	-655M	-479M	-436M	-416M
Per Share Items
Net EPS - Basic	-4	-6.41	-4.28	-3.56	-3.32
Basic EPS - Continuing Operations	-4	-6.41	-4.28	-3.56	-3.32
Basic Weighted Average Shares Outstanding	101M	102M	112M	123M	125M
Net EPS - Diluted	-4	-6.41	-4.28	-3.56	-3.32
Diluted EPS - Continuing Operations	-4	-6.41	-4.28	-3.56	-3.32
Diluted Weighted Average Shares Outstanding	101M	102M	112M	123M	125M
Normalized Basic EPS	-2.73	-3.92	-2.48	-1.99	-1.98
Normalized Diluted EPS	-2.73	-3.92	-2.48	-1.99	-1.98
Supplemental Items
EBITDA	-389M	-508M	-436M	-401M	-397M
EBITA	-409M	-542M	-477M	-441M	-435M
EBIT	-411M	-544M	-479M	-444M	-436M
EBITDAR	-364M	-480M	-407M	-370M	-363M
Total Revenues (As Reported)	374M	450M	564M	739M	-
Effective Tax Rate - (Ratio)	-0.08	-0.17	-0.14	-0.3	0.3
Current Domestic Taxes	4K	127K	35K	126K	90K
Current Foreign Taxes	118K	1.25M	1.19M	871K	352K
Total Current Taxes	122K	1.38M	1.23M	997K	442K
Deferred Domestic Taxes	128K	21K	-	-	-
Deferred Foreign Taxes	50K	-257K	-541K	287K	-1.7M
Total Deferred Taxes	178K	-236K	-541K	287K	-1.7M
Normalized Net Income	-277M	-400M	-277M	-244M	-249M
Interest on Long-Term Debt	2.58M	2.58M	2.58M	2.58M	3.9M
Supplemental Operating Expense Items
Advertising Expense	2.4M	8.9M	2.1M	-	-
Selling and Marketing Expenses	192M	300M	295M	365M	495M
General and Administrative Expenses	207M	164M	156M	180M	210M
Research And Development Expense From Footnotes	263M	374M	367M	348M	364M
Net Rental Expense, Total	24.7M	28.6M	29.7M	31.1M	33.6M
Imputed Operating Lease Interest Expense	457K	430K	450K	477K	688K
Imputed Operating Lease Depreciation	24.24M	28.17M	29.25M	30.62M	32.91M
Stock-Based Comp., COGS (Total)	3.47M	5.5M	6.46M	9.36M	10.7M
Stock-Based Comp., R&D Exp. (Total)	18.91M	26.63M	34.68M	50.57M	50.94M
Stock-Based Comp., S&M Exp. (Total)	15.48M	25.44M	24.76M	36.48M	44.72M
Stock-Based Comp., G&A Exp. (Total)	114M	37.12M	24.85M	44M	59.86M
Total Stock-Based Compensation	151M	94.68M	90.76M	140M	166M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	492M	142M	1.13B	526M	378M
Short Term Investments	441M	870M	35.1M	314M	823M
Total Cash And Short Term Investments	933M	1.01B	1.17B	840M	1.2B
Accounts Receivable, Total	97.65M	97.26M	88.78M	110M	138M
Total Receivables	97.65M	97.26M	88.78M	110M	138M
Inventory	30.67M	51.6M	61.95M	71.08M	85.88M
Prepaid Expenses	53.05M	31.51M	27.74M	33.8M	40.72M
Total Current Assets	1.11B	1.19B	1.35B	1.06B	1.47B
Gross Property Plant And Equipment	369M	430M	430M	445M	504M
Accumulated Depreciation	-54.82M	-88.13M	-127M	-166M	-199M
Net Property Plant And Equipment	314M	342M	303M	279M	305M
Long-term Investments	737M	25M	107M	16.1M	6.5M
Goodwill	3.29M	3.29M	3.29M	3.29M	77.26M
Other Intangibles, Total	14.21M	11.73M	8.98M	6.76M	25.92M
Accounts Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	21.54M	36.45M	17.73M	125M	133M
Total Assets	2.2B	1.61B	1.79B	1.49B	2.01B
Liabilities
Accounts Payable, Total	17.58M	68.91M	51.74M	38.55M	54.44M
Accrued Expenses, Total	64.81M	55.79M	72.74M	83.22M	170M
Current Portion of Leases	12.86M	21.88M	27.95M	29.21M	27.68M
Current Income Taxes Payable	4.22M	-	-	-	-
Unearned Revenue Current, Total	11.33M	17.4M	17.96M	35.47M	50.75M
Other Current Liabilities	83.89M	29.24M	35.52M	39.13M	-
Total Current Liabilities	195M	193M	206M	226M	303M
Long-Term Debt	1.13B	1.14B	1.14B	1.14B	1.5B
Long-Term Leases	226M	210M	186M	164M	178M
Unearned Revenue Non Current	-	-	5M	41.6M	59.7M
Other Non Current Liabilities	3.93M	9.18M	91.01M	51.23M	68.07M
Total Liabilities	1.56B	1.55B	1.63B	1.63B	2.11B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	1K	1K	1K	1K	1K
Additional Paid In Capital	1.66B	1.74B	2.3B	2.44B	2.9B
Retained Earnings	-1.01B	-1.66B	-2.14B	-2.58B	-2.99B
Comprehensive Income and Other	-4.76M	-19.52M	-3.68M	-5.2M	-4.85M
Total Common Equity	645M	60.18M	159M	-140M	-99.31M
Minority Interest	-	-	-	-	-
Total Equity	645M	60.18M	159M	-140M	-99.31M
Total Liabilities And Equity	2.2B	1.61B	1.79B	1.49B	2.01B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	102M	103M	122M	123M	131M
ECS Total Common Shares Outstanding	102M	103M	122M	124M	131M
Book Value / Share	6.34	0.59	1.3	-1.13	-0.76
Tangible Book Value	628M	45.16M	146M	-150M	-202M
Tangible Book Value Per Share	6.17	0.44	1.2	-1.21	-1.55
Total Debt	1.37B	1.37B	1.35B	1.34B	1.71B
Net Debt	-257M	358M	185M	496M	509M
Debt Equivalent Oper. Leases	198M	229M	238M	249M	269M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	30.67M	51.6M	61.95M	71.08M	85.88M
Machinery, Total	83.39M	134M	161M	169M	194M
Full Time Employees	1.37K	1.79K	1.77K	2K	2.49K
Part Time Employees	-	-	11	22	16

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-406M	-655M	-479M	-436M	-416M
Depreciation & Amortization - CF	20.37M	33.46M	40.18M	40.19M	38.04M
Amortization of Goodwill and Intangible Assets - (CF)	1.9M	2.5M	2.7M	2.2M	1.7M
Depreciation & Amortization, Total	22.27M	35.96M	42.88M	42.39M	39.74M
Amortization of Deferred Charges, Total - (CF)	2.56M	2.57M	2.58M	2.58M	-
(Gain) Loss on Sale of Investments - (CF)	12.85M	12.39M	-64.21M	37.63M	12.7M
Asset Writedown & Restructuring Costs	-	5.26M	-	-	-
Provision for Credit Losses	47K	21K	-	-	-
Stock-Based Compensation (CF)	151M	94.68M	90.76M	140M	166M
Other Operating Activities, Total	47.94M	133M	28.63M	34.37M	27.29M
Change In Accounts Receivable	-44.35M	375K	8.38M	-21.39M	-28.18M
Change In Inventories	-7.96M	-20.93M	-10.35M	-9.14M	-14.79M
Change In Accounts Payable	8.64M	60.33M	88.59M	-2.82M	52.75M
Change in Unearned Revenues	2.78M	9.87M	1.73M	18.66M	19.46M
Change in Other Net Operating Assets	428K	11.91M	-34.51M	-46.18M	-43.67M
Cash from Operations	-209M	-309M	-325M	-240M	-185M
Capital Expenditure	-75.04M	-77.46M	-20.49M	-35.08M	-48.31M
Cash Acquisitions	-	-	-	-	-58.99M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	11.88M	227M	859M	-226M	-520M
Other Investing Activities, Total	-	-	1.53M	-	-
Cash from Investing	-63.16M	150M	840M	-261M	-627M
Long-Term Debt Issued, Total	-	-	-	-	402M
Total Debt Issued	-	-	-	-	402M
Long-Term Debt Repaid, Total	-146K	-71K	-	-	-
Total Debt Repaid	-146K	-71K	-	-	-
Issuance of Common Stock	17.86M	11.94M	504M	14.84M	378M
Repurchase of Common Stock	-83.76M	-7.88M	-11.2M	-15.68M	-75.54M
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-784K	-193M	-15.1M	-153K	-33.63M
Cash from Financing	-66.82M	-189M	477M	-996K	671M
Foreign Exchange Rate Adjustments	-1.69M	-1.6M	-911K	-1.77M	491K
Net Change in Cash	-341M	-350M	992M	-504M	-140M
Supplemental Items
Cash Interest Paid	-	-	-	-	3.77M
Cash Income Tax Paid (Refund)	393K	1.33M	1.97M	1.01M	869K
Levered Free Cash Flow	-123M	-296M	-177M	-147M	-88.11M
Unlevered Free Cash Flow	-124M	-297M	-178M	-148M	-85.67M
Change In Net Working Capital	-33.76M	9.47M	-8.52M	18.26M	-29.37M
Net Debt Issued / Repaid	-146K	-71K	-	-	402M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-11.48	-17.84	-17.64	-16.95	-15.59
Return on Total Capital	-12.15	-19.73	-20.36	-20.47	-19.43
Return On Equity %	-38.47	-185.65	-438.12	-4.58K	348.42
Return on Common Equity	-41.75	-185.65	-438.12	-4.58K	348.42
Margin Analysis
Gross Profit Margin %	67.11	65.23	59.74	60.79	64.46
SG&A Margin	106.66	103.17	79.98	73.75	71.8
EBITDA Margin %	-104.04	-113.1	-77.37	-54.29	-40.38
EBITA Margin %	-109.49	-120.54	-84.5	-59.73	-44.26
EBIT Margin %	-110	-121.1	-84.98	-60.02	-44.43
Income From Continuing Operations Margin %	-102.98	-145.61	-85.02	-59.05	-42.39
Net Income Margin %	-108.57	-145.61	-85.02	-59.05	-42.39
Net Avail. For Common Margin %	-108.57	-145.61	-85.02	-59.05	-42.39
Normalized Net Income Margin	-74.08	-89.03	-49.2	-33.04	-25.33
Levered Free Cash Flow Margin	-33.05	-65.75	-31.36	-19.87	-8.97
Unlevered Free Cash Flow Margin	-33.3	-65.96	-31.54	-20	-8.72
Asset Turnover
Asset Turnover	0.17	0.24	0.33	0.45	0.56
Fixed Assets Turnover	1.8	1.37	1.75	2.54	3.36
Receivables Turnover (Average Receivables)	4.95	4.61	6.06	7.43	7.92
Inventory Turnover (Average Inventory)	4.6	3.8	4	4.36	4.45
Short Term Liquidity
Current Ratio	5.72	6.17	6.54	4.68	4.84
Quick Ratio	5.29	5.74	6.11	4.21	4.42
Operating Cash Flow to Current Liabilities	-1.07	-1.6	-1.58	-1.06	-0.61
Days Sales Outstanding (Average Receivables)	73.73	79.13	60.2	49.29	46.11
Days Outstanding Inventory (Average Inventory)	79.27	96.05	91.27	84.01	82.08
Average Days Payable Outstanding	34.75	110.61	92.75	55.27	46.65
Cash Conversion Cycle (Average Days)	118.25	64.56	58.72	78.02	81.53
Long Term Solvency
Total Debt/Equity	212.98	2.28K	853.12	-956.74	-1.72K
Total Debt / Total Capital	68.05	95.79	89.51	111.67	106.16
LT Debt/Equity	210.99	2.24K	835.51	-935.82	-1.69K
Long-Term Debt / Total Capital	67.41	94.26	87.66	109.23	104.45
Total Liabilities / Total Assets	70.74	96.26	91.12	109.4	104.93
EBIT / Interest Expense	-159.49	-211.24	-185.89	-171.87	-111.96
EBITDA / Interest Expense	-141.26	-186.19	-157.74	-143.4	-93.14
(EBITDA - Capex) / Interest Expense	-170.38	-216.25	-165.68	-156.99	-105.53
Total Debt / EBITDA	-3.77	-2.85	-3.33	-3.61	-4.71
Net Debt / EBITDA	0.71	-0.75	-0.46	-1.34	-1.4
Total Debt / (EBITDA - Capex)	-3.13	-2.46	-3.17	-3.3	-4.16
Net Debt / (EBITDA - Capex)	0.59	-0.64	-0.43	-1.22	-1.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	30.32	20.31	25.45	31.04	32.88
Gross Profit, 1 Yr. Growth %	29.12	16.94	14.9	33.34	40.91
EBITDA, 1 Yr. Growth %	62.73	30.79	-13.29	-8.49	-0.91
EBITA, 1 Yr. Growth %	61.6	32.46	-11.21	-7.78	-1.31
EBIT, 1 Yr. Growth %	61.21	32.45	-11.12	-7.84	-1.42
Earnings From Cont. Operations, 1 Yr. Growth %	56.23	70.12	-26.76	-8.98	-4.61
Net Income, 1 Yr. Growth %	59.85	61.36	-26.76	-8.98	-4.61
Normalized Net Income, 1 Yr. Growth %	70.54	44.58	-30.11	-12.41	2.14
Diluted EPS Before Extra, 1 Yr. Growth %	53.84	60	-33.17	-16.96	-6.61
Accounts Receivable, 1 Yr. Growth %	83.22	-0.41	-8.71	24.18	25.03
Inventory, 1 Yr. Growth %	35.03	68.21	20.06	14.75	20.81
Net Property, Plant and Equip., 1 Yr. Growth %	213.51	8.93	-11.47	-7.81	9.2
Total Assets, 1 Yr. Growth %	-2.96	-26.97	10.96	-16.84	35.54
Tangible Book Value, 1 Yr. Growth %	-50.94	-92.8	224.19	-202.24	35.26
Common Equity, 1 Yr. Growth %	-50.33	-90.67	163.68	-188	-28.89
Cash From Operations, 1 Yr. Growth %	101.12	48.06	5.01	-26.19	-22.97
Capital Expenditures, 1 Yr. Growth %	107.43	3.23	-73.55	71.26	37.68
Levered Free Cash Flow, 1 Yr. Growth %	62.87	139.36	-39.49	-17.6	-40.78
Unlevered Free Cash Flow, 1 Yr. Growth %	60.42	138.3	-39.36	-17.51	-41.79
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	32.02	25.21	22.85	28.22	31.96
Gross Profit, 2 Yr. CAGR %	32.12	22.88	15.91	23.78	37.08
EBITDA, 2 Yr. CAGR %	134.05	45.89	5.95	-11.17	-4.88
EBITA, 2 Yr. CAGR %	123.81	46.31	7.93	-9.75	-4.7
EBIT, 2 Yr. CAGR %	123.37	46.12	7.98	-9.73	-4.78
Earnings From Cont. Operations, 2 Yr. CAGR %	138.13	63.03	11.63	-18.35	-6.82
Net Income, 2 Yr. CAGR %	131.57	60.6	8.71	-18.35	-6.82
Normalized Net Income, 2 Yr. CAGR %	132.12	57.57	0.11	-21.89	-5.52
Diluted EPS Before Extra, 2 Yr. CAGR %	118.98	56.89	3.4	-25.51	-11.94
Accounts Receivable, 2 Yr. CAGR %	42.65	35.08	-4.65	6.47	24.61
Inventory, 2 Yr. CAGR %	42.15	50.71	42.11	17.37	17.74
Net Property, Plant and Equip., 2 Yr. CAGR %	107.64	84.8	-1.8	-9.66	0.34
Total Assets, 2 Yr. CAGR %	51.34	-15.82	-9.98	-3.94	6.17
Tangible Book Value, 2 Yr. CAGR %	-10.29	-81.21	-51.7	82.06	17.6
Common Equity, 2 Yr. CAGR %	-10.12	-78.47	-50.4	52.33	-20.89
Cash From Operations, 2 Yr. CAGR %	110.58	72.56	24.69	-11.96	-24.6
Capital Expenditures, 2 Yr. CAGR %	100.22	46.34	-47.75	-32.7	53.56
Levered Free Cash Flow, 2 Yr. CAGR %	55.58	97.44	19.69	-29.52	-30.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	57.32	95.52	19.55	-29.4	-30.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	60.34	28	25.29	25.52	29.75
Gross Profit, 3 Yr. CAGR %	74.2	26.85	20.16	21.45	29.24
EBITDA, 3 Yr. CAGR %	65.47	92.78	22.24	1.06	-7.95
EBITA, 3 Yr. CAGR %	64.42	87.91	23.47	2.56	-7.09
EBIT, 3 Yr. CAGR %	64.14	87.66	23.41	2.58	-7.11
Earnings From Cont. Operations, 3 Yr. CAGR %	65.9	112.88	24.86	4.28	-14.01
Net Income, 3 Yr. CAGR %	68.32	105.3	23.62	2.46	-14.01
Normalized Net Income, 3 Yr. CAGR %	70.25	98.23	19.84	-4.1	-14.66
Diluted EPS Before Extra, 3 Yr. CAGR %	12.69	97.23	18.04	-3.89	-19.67
Accounts Receivable, 3 Yr. CAGR %	39.87	26.55	18.54	4.13	12.33
Inventory, 3 Yr. CAGR %	49.74	50.35	39.71	32.33	18.51
Net Property, Plant and Equip., 3 Yr. CAGR %	116.34	67.46	44.6	-3.84	-3.76
Total Assets, 3 Yr. CAGR %	55.4	18.7	-7.7	-12.33	7.74
Tangible Book Value, 3 Yr. CAGR %	9.7	-61.31	-51.45	-37.98	64.89
Common Equity, 3 Yr. CAGR %	10.11	-57.76	-50.38	-39.95	18.17
Cash From Operations, 3 Yr. CAGR %	42.53	87.25	46.23	4.69	-15.8
Capital Expenditures, 3 Yr. CAGR %	54.86	60.55	-17.26	-22.38	-14.56
Levered Free Cash Flow, 3 Yr. CAGR %	23.23	79.6	32.63	5.94	-33.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	24.04	80.67	31.86	5.9	-33.89
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	71.41	55.25	44.14	28.08	27.92
Gross Profit, 5 Yr. CAGR %	140.37	74.3	48.01	25.61	26.66
EBITDA, 5 Yr. CAGR %	57.46	49.36	38.44	41.41	10.67
EBITA, 5 Yr. CAGR %	56.31	49.07	38.94	40.14	11.41
EBIT, 5 Yr. CAGR %	56.45	49.21	38.82	40.04	11.34
Earnings From Cont. Operations, 5 Yr. CAGR %	52.84	51.06	41.59	45.1	11.07
Net Income, 5 Yr. CAGR %	54.46	51.06	41.32	41.97	10.4
Normalized Net Income, 5 Yr. CAGR %	57.2	53.5	37.67	36.58	9.07
Diluted EPS Before Extra, 5 Yr. CAGR %	2.52	-1.96	8.88	33.61	4.99
Accounts Receivable, 5 Yr. CAGR %	94.65	50.05	19.99	18.1	20.93
Inventory, 5 Yr. CAGR %	61.77	47.92	46.64	36.17	30.47
Net Property, Plant and Equip., 5 Yr. CAGR %	90.13	84.4	57.73	30.83	24.94
Total Assets, 5 Yr. CAGR %	80.03	36.25	24.91	9.07	-2.38
Tangible Book Value, 5 Yr. CAGR %	44.3	-25.75	-20.98	-28.11	-30.83
Common Equity, 5 Yr. CAGR %	45.09	-20.66	-19.96	-29.44	-40.2
Cash From Operations, 5 Yr. CAGR %	41.61	33.77	35.11	38.46	12.2
Capital Expenditures, 5 Yr. CAGR %	111.67	63.25	0.28	13.39	5.96
Levered Free Cash Flow, 5 Yr. CAGR %	-	39.32	21.8	23.54	3.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	40.27	22.22	24.07	2.01